Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population.

.

Inclusion Criteria:

• Metabolic or endocrine disease

Exclusion Criteria:

• Known myopathy
• Systemic steroid use (> 1 mg/kg hydrocortisone) or exogenous Cushing's syndrome
• Psychological, family, sociological or geographical conditions that could potentially limit compliance with the study protocol
• History of cancer within the five years prior to the study or Cushing's syndrome due to ACTH-secreting tumor